Hikmat Al-Ahmadie

44PUBLICATIONS
363CO-AUTHORS
Predictive and prognostic markersCancer diagnosisSolid tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Oct 20, 2026
Mutational Signatures and Hypermutation Phenotypes Define Bladder Cancers Arising in Waterpipe and Cigarette Smokers.

|Aug 05, 2026
Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.

|Jul 23, 2026
Induction and characterization of neoplastic bladder tumors in a transgenic porcine model.

|Jun 26, 2026
Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

|Feb 09, 2026
Urinary Biomarkers Objectively Measure Minimal Residual Disease in Non-Muscle-Invasive Bladder Cancer.

Andrew B Katims, Charlie White, Syed Muneeb Alam

|Feb 02, 2026
Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer.

Brendan J Guercio, Eugene J Pietzak, Vignesh Ravichandran

Pageof 8

Frequent Collaborators

18 joint publications

David Solit

17 joint publications

Gopakumar V Iyer

14 joint publications

Samuel Funt

13 joint publications

Jonathan E Rosenberg